{Reference Type}: Journal Article
{Title}: Establishment of human embryonic stem cell lines carrying LQT1 mutations by CRISPR base editing.
{Author}: Wang X;Gao J;Liu C;Sun J;
{Journal}: Stem Cell Res
{Volume}: 79
{Issue}: 0
{Year}: 2024 Sep 14
{Factor}: 1.587
{DOI}: 10.1016/j.scr.2024.103496
{Abstract}: The KCNQ1 gene encodes a voltage-gated potassium channel required for cardiac action potentials. Mutations in this gene have been associated with hereditary long QT syndrome 1, Jervell and Lange-Nielsen syndromes, and familial atrial fibrillation. The NM_000218.3(KCNQ1): c.604 + 2T > C mutation has been categorized as the causative variant leading to LQT1. In this study, we generated a KCNQ1 (c.644 + 2T > C) mutation human embryonic stem cell line WAe009-A-1L based on CRISPR base editing system. WAe009-A-1L cell has the potential to differentiate cardiomyocytes and would be used as an in vitro disease model for mechanism exploration and drug screening.